RxDoctor Payments Data

Rajul Kothari, MD

Gynecologic Oncology · Chicago, ILNPI 1518160720

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $954 of the $1,540 with a category attached, or 61.9%. 23 manufacturers reported payments, led by Stryker at 52.5% of the total. Reporting peaked in 2022 at $1,042 and has fallen 97.5% since, to $26 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in IL, where the typical reported total is $1,540.

$1,540in general payments, 2019–2025

Across 40 payments — averaging $38.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$809
  • Sirtex Medical Inc$95
  • Merck$55
  • Idorsia Pharmaceuticals US Inc$55
  • AstraZeneca$50
  • GSK$48
  • plus $428 from 17 others

What the payments were for

  • Travel & lodging$58638%
  • Food & beverage$95462%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,540 in reported general payments places this provider in the 50th percentile of 64 gynecologic oncology providers in Illinois.

See all gynecologic oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$22,030
Medicare patients
33
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →